+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen & PMMA Microspheres, HA), By Application (Facial Line Correction, Lip Augmentation), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • March 2025
  • Region: Global
  • Grand View Research
  • ID: 4312576
REQUEST CUSTOMIZATION
Description Jump to:
The global facial injectable market size is expected to reach USD 24.9 billion by 2030, registering a CAGR of 12.3% from 2025 to 2030, The facial injectables are crucial in anti-aging treatments and are particularly used to stop damage such as hyperpigmentation and early aging. The most popular treatments across all socioeconomic groups are Botox and fillers, which have gained immense popularity.

Growing focus on physical appearance, especially in developing countries is one of the key factors expected to drive the market. In addition, a shift in consumer preference towards minimally invasive procedures is also expected to support market growth. According to the American Society of Plastic Surgeons (ASPS), in 2020, botulinum toxin A and soft tissue fillers were among the top 5 minimally invasive procedures carried out in the U.S. Thus, facial injectable holds high growth prospects in the years to come.

The onset of the pandemic led to nonurgent and cosmetic surgeries being put on hold in the first and second quarters of 2020. Since there were stringent restrictions imposed by the authority bodies as a precaution, the coronavirus outbreak has had an impact on every industry, including the cosmetics industry. Aesthetics-related product supply chains were also impacted. The demand-supply chain across the whole medical device sector has been severely disrupted by the pandemic.

Facial Injectable Market Report Highlights

  • Based on product, the botulinum toxin type A segment is projected to dominate the market throughout the forecast period. It is one of the most popularly used minimally invasive procedures
  • Based on application, the facial line correction segment dominated the market and accounted for the largest revenue share of 33.2% in 2024. This growth is owing to the increasing use of facial injectables for aesthetic procedures such as facial lines, wrinkles on the face, and lip lines
  • Based on end-use, the medSpa segment dominated the market and held the largest revenue share of 47.0% in 2024. All noninvasive treatments are performed in these facilities, which include facial injections, non-invasive body contouring, skin rejuvenation, and laser treatments by experienced professionals
  • North America dominated the market with a revenue share of 38.9% in 2024 owing to the easy availability of the products and the presence of a large number of skilled surgeons
  • The Asia Pacific region is expected to serve as a key revenue-generating center. The region is backed by countries such as India, where a growing focus on physical appearance is expected to create a lucrative opportunity for the market

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This Report Addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Facial Injectable Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing beauty consciousness among consumers
3.2.1.2. Shift in consumer preference towards minimally invasive procedures
3.2.2. Market restraint analysis
3.2.2.1. High cost of treatment
3.3. Facial Injectable Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Facial Injectable Market: Product Estimates & Trend Analysis
4.1. Global Facial Injectable Market: Product Dashboard
4.2. Global Facial Injectable Market: Product Movement Analysis
4.3. Global Facial Injectable Market by Product, Revenue
4.4. Collagen & PMMA Microspheres
4.4.1. Collagen & PMMA microspheres market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Botulinum Toxin Type A
4.5.1. Botulinum toxin Type A market estimates and forecasts 2018 to 2030 (USD Million)
4.6. HA
4.6.1. HA market estimates and forecasts 2018 to 2030 (USD Million)
4.7. CaHA
4.7.1. CaHa market estimates and forecasts 2018 to 2030 (USD Million)
4.8. PLLA
4.8.1. PLLA market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Others
4.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Facial Injectable Market: Application Estimates & Trend Analysis
5.1. Global Facial Injectable Market: Application Dashboard
5.2. Global Facial Injectable Market: Application Movement Analysis
5.3. Global Facial Injectable Market Estimates and Forecasts, By Application, Revenue (USD Million)
5.4. Facial Line Correction
5.4.1. Facial line correction market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Lip Augmentation
5.5.1. Lip augmentation market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Face Lift
5.6.1. Face lift market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Acne Scar Treatment
5.7.1. Acne scar treatment market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Lipoatrophy Treatment
5.8.1. Lipoatrophy treatment market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Facial Injectable Market: End Use Estimates & Trend Analysis
6.1. Global Facial Injectable Market: End use Dashboard
6.2. Global Facial Injectable Market: End use Movement Analysis
6.3. Global Facial Injectable Market Estimates and Forecasts, by End use, Revenue (USD Million)
6.4. MedSpa
6.4.1. MedSpa market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Dermatology Clinics
6.5.1. Dermatology Clinics market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Hospitals
6.6.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Others
6.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Facial Injectable Market: Regional Estimates & Trend Analysis by Product, Application, and End use
7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Mexico
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.1.1. Key company market share analysis, 2024
8.1.2. Ispen
8.1.2.1. Company overview
8.1.2.2. Financial performance
8.1.2.3. Product benchmarking
8.1.2.4. Strategic initiatives
8.1.3. Abbvie
8.1.3.1. Company overview
8.1.3.2. Financial performance
8.1.3.3. Product benchmarking
8.1.3.4. Strategic initiatives
8.1.4. Medytox Inc.
8.1.4.1. Company overview
8.1.4.2. Financial performance
8.1.4.3. Product benchmarking
8.1.4.4. Strategic initiatives
8.1.5. Merz GmbH and Co. KGaA
8.1.5.1. Company overview
8.1.5.2. Financial performance
8.1.5.3. Product benchmarking
8.1.5.4. Strategic initiatives
8.1.6. Revance Therapeutics, Inc.
8.1.6.1. Company overview
8.1.6.2. Financial performance
8.1.6.3. Product benchmarking
8.1.6.4. Strategic initiatives
8.1.7. Galderma
8.1.7.1. Company overview
8.1.7.2. Financial performance
8.1.7.3. Product benchmarking
8.1.7.4. Strategic initiatives
8.1.8. Sinclair Pharma
8.1.8.1. Company overview
8.1.8.2. Financial performance
8.1.8.3. Product benchmarking
8.1.8.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America Facial Injectable Market, by region, 2018 - 2030 (USD Million)
Table 3 North America Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 4 North America Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 5 North America Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 6 U.S. Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 7 U.S. Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 9 Canada Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 10 Canada Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 11 Canada Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 12 Europe Facial Injectable Market, by region, 2018 - 2030 (USD Million)
Table 13 Europe Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 14 Europe Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 15 Europe Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 16 Germany Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 17 Germany Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 18 Germany Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 19 UK Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 20 UK Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 21 UK Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 22 France Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 23 France Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 24 France Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 25 Italy Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 26 Italy Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 27 Italy Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 28 Spain Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 29 Spain Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 30 Spain Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 31 Denmark Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 32 Denmark Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 33 Denmark Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 34 Sweden Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 35 Sweden Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 36 Sweden Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 37 Norway Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 38 Norway Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 39 Norway Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 40 Asia Pacific Facial Injectable Market, by region, 2018 - 2030 (USD Million)
Table 41 Asia Pacific Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 42 Asia Pacific Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 43 Asia Pacific Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 44 China Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 45 China Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 46 China Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 47 Japan Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 48 Japan Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 49 Japan Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 50 India Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 51 India Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 52 India Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 53 South Korea Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 54 South Korea Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 55 South Korea Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 56 Australia Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 57 Australia Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 58 Australia Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 59 Thailand Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 60 Thailand Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 61 Thailand Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 62 Latin America Facial Injectable Market, by region, 2018 - 2030 (USD Million)
Table 63 Latin America Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 64 Latin America Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 65 Latin America Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 66 Brazil Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 67 Brazil Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 68 Brazil Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 69 Mexico Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 70 Mexico Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 71 Mexico Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 72 Argentina Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 73 Argentina Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 74 Argentina Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 75 MEA Facial Injectable Market, by region, 2018 - 2030 (USD Million)
Table 76 MEA Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 77 MEA Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 78 MEA Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 79 South Africa Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 80 South Africa Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 81 South Africa Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 85 UAE Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 86 UAE Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 87 UAE Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
Table 88 Kuwait Facial Injectable Market, by product, 2018 - 2030 (USD Million)
Table 89 Kuwait Facial Injectable Market, by application, 2018 - 2030 (USD Million)
Table 90 Kuwait Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Facial Injectable Market: market outlook
Fig. 9 Facial injectables competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Facial Injectable Market driver impact
Fig. 13 Facial Injectable Market restraint impact
Fig. 14 Facial Injectable Market: Product movement analysis
Fig. 15 Facial Injectable Market: Product outlook and key takeaways
Fig. 16 Collagen & PMMA microspheres market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Botulinum toxin Type A market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 HA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 CaHA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 PLLA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Facial Injectable Market: Application movement analysis
Fig. 23 Facial Injectable Market: Application outlook and key takeaways
Fig. 24 Facial Line Correction market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Lip augmentation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Face lift market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Acne scar treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Lipoatrophy treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Facial Injectable Market: End use movement analysis
Fig. 31 Facial Injectable Market: End use outlook and key takeaways
Fig. 32 MedSpa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Dermatology clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Global Facial Injectable Market: Regional movement analysis
Fig. 36 Global Facial Injectable Market: Regional outlook and key takeaways
Fig. 37 Global Facial Injectable Market share and leading players
Fig. 38 North America, by country
Fig. 39 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 U.S. key country dynamics
Fig. 41 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Canada key country dynamics
Fig. 43 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 UK key country dynamics
Fig. 46 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Germany key country dynamics
Fig. 48 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 France key country dynamics
Fig. 50 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Italy key country dynamics
Fig. 52 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Spain key country dynamics
Fig. 54 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Denmark key country dynamics
Fig. 56 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Sweden key country dynamics
Fig. 58 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Norway key country dynamics
Fig. 60 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 China key country dynamics
Fig. 63 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Japan key country dynamics
Fig. 65 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 India key country dynamics
Fig. 67 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Thailand key country dynamics
Fig. 69 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 South Korea key country dynamics
Fig. 71 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Australia key country dynamics
Fig. 73 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Brazil key country dynamics
Fig. 76 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Mexico key country dynamics
Fig. 78 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Argentina key country dynamics
Fig. 80 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 South Africa key country dynamics
Fig. 83 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Saudi Arabia key country dynamics
Fig. 85 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 UAE key country dynamics
Fig. 87 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Kuwait key country dynamics
Fig. 89 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • Ispen
  • Abbvie
  • Medytox Inc.
  • Merz GmbH and Co. KGaA
  • Revance Therapeutics, Inc.
  • Galderma
  • Sinclair Pharma

Table Information

Report AttributeDetails
No. of Pages100
PublishedMarch 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 12.53 Billion
Forecasted Market Value ( USD ) by 2030 $ 24.9 Billion
Compound Annual Growth Rate12.3%
Regions CoveredGlobal
No. of Companies Mentioned7

Related Topics

Related Reports

PMMA-Based Injectable Filler Market - Global Forecast 2025-2030 - Product Image

PMMA-Based Injectable Filler Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Polynucleotides Injectable Market Size, Share & Trends Analysis Report By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Polynucleotides Injectable Market Size, Share & Trends Analysis Report By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Sterile Injectables CDMO Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, Large Molecule), By Product, By Service, By Therapeutic Area, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Sterile Injectables CDMO Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, Large Molecule), By Product, By Service, By Therapeutic Area, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Injectable Botulinum Toxin Type a Market - Global Forecast 2025-2030 - Product Image

Injectable Botulinum Toxin Type a Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Facial Injectables Market Size, Share, Trends and Forecast by Product Type, Application Type, Application, End User, and Region, 2025-2033 - Product Image

Facial Injectables Market Size, Share, Trends and Forecast by Product Type, Application Type, Application, End User, and Region, 2025-2033

  • Report
  • 136 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.